AXTI
AXT, Inc.
AXTI offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
IBM
International Business Machines Corporation
IBM has a slight edge over AXTI overall, supported by stronger valuation and lower modeled downside.
AXTI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
AXTI's revenue, profitability, cash flow and balance sheet are all currently strong.
IBM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Under pressure |
IBM's profitability and cash flow are currently strong, and its revenue is stable, but its balance sheet is under pressure.
AXTI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $5.95 | -86% |
| Forward | 18x | $43.54 | — |
| Fair | 23x | $9.92 | -77% |
| Expensive | 96x | $42.09 | -3.3% |
| Current | 99x | $43.54 | — |
Historical ranges are pointers, not guarantees.
AXTI's PE is in its expensive range at 99x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its fair range.
IBM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $194 | -21% |
| Forward | 19x | $245 | — |
| Current | 21x | $245 | — |
| Fair | 23x | $274 | +12% |
| Expensive | 46x | $538 | +120% |
Historical ranges are pointers, not guarantees.
IBM has the edge over AXTI in the historical PE scenario, which offers more potential upside but is not a forecast.
AXTI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
AXTI has the edge over IBM on the outlook, with more favorable revenue expectations.
IBM Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect IBM's earnings to grow and its profitability to improve, with its revenue holding steady.
AXTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.40 | +445% |
| Q3 2026 | $0.44 | +$0.95 |
| Q2 2026 | $0.01 | +$0.55 |
| Q1 2026 | -$0.32 | +$0.10 |
| Q4 2025 | -$0.49 | -$0.22 |
| Q3 2025 | -$0.51 | -$0.26 |
| Q2 2025 | -$0.54 | -$0.22 |
| Q1 2025 | -$0.42 | -$0.02 |
| Q4 2024 | -$0.27 | +$0.16 |
AXTI has returned to profit: it earned $0.44 per share over the past year, after losing money the year before.
IBM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.06 | +11% |
| Q3 2026 | $11.75 | +40% |
| Q2 2026 | $11.29 | +83% |
| Q1 2026 | $11.33 | +94% |
| Q4 2025 | $11.17 | +74% |
| Q3 2025 | $8.38 | +22% |
| Q2 2025 | $6.18 | -32% |
| Q1 2025 | $5.83 | -34% |
| Q4 2024 | $6.43 | -21% |
IBM has the edge over AXTI on earnings, with more consistent year-over-year improvement.
AXTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $73.4M | +163% |
| Q2 2026 | $47.6M | +165% |
| Q1 2026 | $26.9M | +39% |
| Q4 2025 | $23M | -8.2% |
| Q3 2025 | $28M | +18% |
| Q2 2025 | $18M | -36% |
| Q1 2025 | $19.4M | -15% |
| Q4 2024 | $25.1M | +23% |
AXTI's revenue is growing: $73M last quarter, up 163% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +43 points |
| Q2 2026 | 22% | +59 points |
| Q1 2026 | -5.9% | +47 points |
| Q4 2025 | -17% | +7.9 points |
| Q3 2025 | -4% | +10 points |
| Q2 2025 | -38% | -31 points |
| Q1 2025 | -53% | -38 points |
| Q4 2024 | -25% | -7.1 points |
AXTI has the edge over IBM on profitability, with a higher operating margin.
IBM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $17.1B | +4.7% |
| Q2 2026 | $17.2B | +1.1% |
| Q1 2026 | $15.9B | +9.5% |
| Q4 2025 | $19.7B | +12% |
| Q3 2025 | $16.3B | +9.1% |
| Q2 2025 | $17B | +7.7% |
| Q1 2025 | $14.5B | +0.5% |
| Q4 2024 | $17.6B | +1% |
IBM's revenue has grown year over year for 13 quarters in a row: $17.1B last quarter, up 4.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | -0.3 points |
| Q2 2026 | 14% | -0.9 points |
| Q1 2026 | 8.7% | +0.8 points |
| Q4 2025 | 21% | +2.2 points |
| Q3 2025 | 15% | +20 points |
| Q2 2025 | 15% | +1.2 points |
| Q1 2025 | 8% | +0.5 points |
| Q4 2024 | 19% | -2.8 points |
IBM's operating margin was 15% last quarter, about level with the same quarter a year ago.
AXTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $87.7M | +$99M |
| Q2 2026 | $3.6M | +$8.4M |
| Q1 2026 | -$13.1M | -$9.2M |
| Q4 2025 | $1.3M | +14% |
| Q3 2025 | -$11.3M | -$5M |
| Q2 2025 | -$4.9M | -949% |
| Q1 2025 | -$3.9M | +$9.3M |
| Q4 2024 | $1.1M | -48% |
AXTI's free cash flow has turned positive after six years mostly in the red: $79M over the past year.
IBM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +31% |
| Q2 2026 | $2.4B | +59% |
| Q1 2026 | $4.9B | +20% |
| Q4 2025 | $3.7B | -9.2% |
| Q3 2025 | $2.8B | +8.9% |
| Q2 2025 | $1.5B | -19% |
| Q1 2025 | $4.1B | +5% |
| Q4 2024 | $4B | -3.3% |
IBM has the edge over AXTI on cash flow, with more consistent year-over-year improvement.
AXTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.8% | +2.4M shares |
| 1 year | +51% | +22.2M shares |
| 3 years | +55% | +23.3M shares |
| 5 years | +54% | +23.1M shares |
| Available history | +67% | +26.4M shares |
AXTI has 66M diluted shares, up 51% from a year ago.
IBM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +260K shares |
| 1 year | +0.5% | +4.6M shares |
| 3 years | +3.2% | +29.9M shares |
| 5 years | +5.3% | +47.6M shares |
| Available history | +2.1% | +19.6M shares |
IBM has the edge over AXTI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
AXTI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -9.2x | Net Cash |
| Q2 2026 | -24.4x | Net Cash |
| Q2 2023 | 93.9x | High |
| Q1 2023 | 5.5x | High |
| Q4 2022 | 2.9x | Moderate |
| Q3 2022 | 2.2x | Moderate |
| Q2 2022 | -0.4x | Net Cash |
| Q1 2022 | -0.5x | Net Cash |
AXTI has the edge over IBM on leverage, with a lower net debt burden relative to earnings.
IBM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.9x | Elevated |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 4.0x | High |
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 4.2x | High |
| Q2 2025 | 5.5x | High |
| Q1 2025 | 5.6x | High |
| Q4 2024 | 4.4x | High |
IBM's net debt is about 3.9 years of its operating earnings (EBITDA), down from 4.2 years a year ago.
AXTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.5 | Neutral |
| Stochastic | 15.1 | Oversold |
AXTI's weekly RSI is 43 (neutral) and its Stochastic is 15 (oversold).
IBM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 74.8 | Neutral |
IBM's weekly RSI is 50 (neutral) and its Stochastic is 75 (neutral).
AXTI PE vs Technology Sector
| Metric | AXTI | Sector median | Relative |
|---|---|---|---|
| PE | 99x | 28x | 255% above |
| PE % | 83 | 35 | 48 pts above |
AXTI is trading at 99x earnings, a 255% premium to the Technology sector's median of 28x.
IBM PE vs Technology Sector
| Metric | IBM | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 31 | 35 | 4 pts below |
IBM has the edge over AXTI on valuation relative to its sector.
AXTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $59.3 | 27% below |
| 20 week MA | $61.9 | 30% below |
| 50 week MA | $58.0 | 25% below |
| 100 week MA | $30.5 | 43% above |
| 200 week MA | $16.8 | 159% above |
AXTI has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 159% above its 200-week average.
IBM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $238.6 | 2.6% above |
| 20 week MA | $239.3 | 2.2% above |
| 50 week MA | $256.6 | 4.6% below |
| 100 week MA | $258.5 | 5.3% below |
| 200 week MA | $212.3 | 15% above |
IBM has the edge over AXTI on trend strength, trading above more of its moving averages.
AXTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.04 | $9.64 | +139% |
| 2021 | $9.64 | $8.80 | -8.7% |
| 2022 | $8.80 | $4.40 | -50% |
| 2023 | $4.40 | $2.40 | -45% |
| 2024 | $2.40 | $2.28 | -5% |
| 2025 | $2.28 | $15.4 | +574% |
| 2026 YTD | $15.4 | $43.5 | +183% |
AXTI has the edge over IBM on returns for 2026, with the stronger performance.
IBM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $129.3 | $119.2 | -7.8% |
| 2021 | $119.2 | $130.6 | +9.6% |
| 2022 | $130.6 | $141.7 | +8.4% |
| 2023 | $141.7 | $163.6 | +15% |
| 2024 | $163.6 | $222.8 | +36% |
| 2025 | $222.8 | $305.1 | +37% |
| 2026 YTD | $305.1 | $244.7 | -20% |
IBM has finished higher in five of the last six years. It's down 20% so far in 2026.